Philippe Laffont is an Analyst at Catalio Capital Management, LP.
He worked for three years at the Translational Tissue Engineering Center at Johns Hopkins. He now works with Catalio Chief Scientist, Dr. Justin Hanes, at his lab at the Department of Nanomedicine at Johns Hopkins Medicine.
Philippe earned a B.S. in Chemical and Biomolecular Engineering from the Johns Hopkins University.